This topic contains a solution. Click here to go to the answer

Author Question: Although both perfectly competitive and monopolistically competitive firms earn normal profits in ... (Read 86 times)

CBme

  • Hero Member
  • *****
  • Posts: 548
Although both perfectly competitive and monopolistically competitive firms earn normal profits in the long run, monopolistically competitive firms will not
 a. operate where price equals marginal cost
  b. charge a higher price than firms in perfect competition
  c. produce a smaller quantity than firms in perfect competition
  d. produce where price equals average total cost
  e. exit when demand falls below long-run average costs

Question 2

With special-interest legislation,
 a. benefits are concentrated but costs are widespread
  b. both benefits and costs are concentrated
  c. benefits are widespread but costs are concentrated
  d. both benefits and costs are widespread
  e. there is no predictable relationship between costs and benefits



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Sassygurl126

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

A

Answer to Question 2

A




CBme

  • Member
  • Posts: 548
Reply 2 on: Jun 30, 2018
Great answer, keep it coming :)


bdobbins

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

Urine turns bright yellow if larger than normal amounts of certain substances are consumed; one of these substances is asparagus.

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library